(Press-News.org) (TORONTO, Canada – May 22, 2014) – A first-ever study from a large Canadian centre found that kidney transplant recipients lived longer and had better treatment success than patients on intensive home hemodialysis, but also had an increased risk of being hospitalized within the first year.
These findings were reported in a study entitled, "Survival and hospitalization for intensive home hemodialysis and kidney transplantation", by lead author Dr. Karthik Tennankore, nephrologist at Dalhousie University, and Drs. Chris Chan and Joseph Kim, nephrologists at Toronto General Hospital, University Health Network. The study was published online on May 22, 2014 in the Journal of the American Society of Nephrology (JASN).
The research reaffirms the need to encourage patients receiving intensive home hemodialysis to pursue kidney transplantation as a definitive treatment option for end-stage kidney disease. However, the study also found that the outcomes for these specific dialysis patients were generally positive, especially when compared to patients on in-centre hemodialysis (intensive home hemodialysis patient survival was 94% and 80% at one and five years).
"For patients with end-stage kidney disease, a kidney transplant is still the best treatment option," says Dr. Chris Chan, Deputy Director, Division of Nephrology, University Health Network, R. Fraser Elliott Chair in Home Dialysis and Associate Professor of Medicine, University of Toronto. "But not everyone is a candidate for a transplant and we are facing a shortage of organs for these patients. We must continue to study and develop new and better ways to bridge the gap, and that includes developing better dialysis treatments."
Dialysis will continue to be an important treatment option for many patients, points out Dr. Karthik Tennankore, Division of Nephrology, Dalhousie University. "This study also tells us that patients who are receiving this type of dialysis still have very good health outcomes."
Due to long waiting times for kidney transplants – up to 10 years in the Greater Toronto Area (GTA) depending on blood type and other factors - the authors note that it is important to identify "bridging therapies" for patients with end-stage kidney disease.
Kidney transplantation remains the gold standard for kidney failure treatment, but intensive home hemodialysis (16 hours or more of treatments a week) is emerging as a treatment option with many clinical advantages, such as minimal adverse reactions, low rates of hospital admission and hospital stay, and superior outcomes to conventional in-centre dialysis treatment, which is usually given three times a week.
While studies have previously shown that in-centre dialysis does not have the same benefits as a kidney transplant, it is not clear how intensive home hemodialysis compares with kidney transplantation.
This observational study looked at 1,690 patients, comparing 173 patients on intensive home hemodialysis to 1,517 kidney transplant recipients from both deceased and living donors who received their transplants at Toronto General Hospital, University Health Network from 2000 to 2011.
The study found that kidney transplant patients had a 55% to 61% reduced risk of treatment failure or death during the study period when compared to the home hemodialysis patients. The risk of being admitted to the hospital and spending a longer time in the hospital was higher for some kidney transplant recipients up to a year after transplantation, likely due to surgical complications, infections, acute rejection, and other related issues. However, the risk of hospitalizations was lower for kidney transplant recipients in the long-term when compared to home hemodialysis patients, with the latter likely related to the development of late-dialysis complications.
At the time of the study, Dr. Karthik Tennankore was the Baxter - University Health Network Home Dialysis Fellow.
INFORMATION:
About Toronto General Hospital
Toronto General Hospital is a partner in University Health Network, along with Toronto Western, the Princess Margaret Cancer Centre and Toronto Rehabilitation Institute. The scope of research and complexity of cases at Toronto General Hospital have made it a national and international source for discovery, education and patient care. It has one of the largest hospital-based research programs in Canada, with major research in cardiology, transplantation, surgical innovation, infectious diseases, genomic medicine and rehabilitation. Toronto General Hospital is a research and teaching hospital affiliated with the University of Toronto. http://www.uhn.ca
For all media requests, please contact:
Alex Radkewycz
Toronto General Hospital, University Health Network
Ph: 416 - 340 – 3895
BB: 647 – 821 - 4624
Email: Alexandra.Radkewycz@uhn.ca
Follow us:
http://www.UHN.ca
@UHN_News
Facebook.com/UniversityHealthNetwork
Kidney transplant patients live longer than those in intensive home hemodialysis
2014-05-23
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Promising discovery in the fight against antibiotic-resistant bacteria
2014-05-23
Researchers at the University of British Columbia have identified a small molecule that prevents bacteria from forming into biofilms, a frequent cause of infections. The anti-biofilm peptide works on a range of bacteria including many that cannot be treated by antibiotics.
"Currently there is a severe problem with antibiotic-resistant organisms," says Bob Hancock, a professor in UBC's Dept. of Microbiology and Immunology and lead author of the study published today in PLOS Pathogens. "Our entire arsenal of antibiotics is gradually losing effectiveness."
Many bacteria ...
Children with cochlear implants at risk for deficits in executive function
2014-05-22
Children who receive cochlear implants (CI) to help alleviate severe to profound hearing loss are at greater risk of having deficiencies in executive functioning (EF), which are the skills to organize, control and process information in a goal-directed manner.
Permanent hearing loss is a common condition of early childhood, occurring in about 1.5 of every 1,000 births. Cochlear implants help children to achieve spoken language because the devices help them perceive sound. Still, children with cochlear implants can struggle with reading and writing skills and other ...
IU researchers identify pattern of cognitive risks in some children with cochlear implants
2014-05-22
INDIANAPOLIS -- Children with profound deafness who receive a cochlear implant had as much as five times the risk of having delays in areas of working memory, controlled attention, planning and conceptual learning as children with normal hearing, according to Indiana University research published May 22 in the Journal of the American Medical Association Otolaryngology--Head and Neck Surgery.
The authors evaluated 73 children implanted before age 7 and 78 children with normal hearing to determine the risk of deficits in executive functioning behaviors in everyday life.
Executive ...
One-third of all brain aneurysms rupture: the size is not a significant risk factor
2014-05-22
VIDEO:
This video depicts microneurosurgical clipping of an unruptured intracranial aneurysm,
which is arising from the bifurcation i.e. branching point of two right
middle cerebral arteries.
In brief, the aneurysm locates in this...
Click here for more information.
The lifetime risk for rupture of a brain aneurysm depends heavily on the patient's overall load of risk factors. However, a recent study by researchers from the University of Helsinki and Helsinki University ...
Clinical trials designed to block autophagy in multiple cancers show promise
2014-05-22
PHILADELPHIA— In the largest group of results to date, researchers from Penn Medicine's Abramson Cancer Center and other institutions have shown in clinical trials that the malaria drug hydroxychloroquine (HCQ) blocked autophagy in a host of aggressive cancers—glioblastoma, melanoma, lymphoma and myeloma, renal and colon cancers—and in some cases helped stabilize disease. Autophagy—an essential process cancer cells need to fuel their growth—is a key troublemaker spurring tumor growth. Block this pathway, many preclinical studies suggest, and anti-cancer agents such as chemotherapy ...
Yale Cancer Center studies find lifestyle changes improve biomarkers for breast cancer recurrence and mortality
2014-05-22
New Haven, CT – A pair of Yale Cancer Center interventional studies involving breast cancer survivors found that lifestyle changes in the form of healthy eating and regular exercise can decrease biomarkers related to breast cancer recurrence and mortality. The abstracts are scheduled to be presented at the 2014 annual meeting of the American Society of Clinical Oncology in Chicago May 30-June 3rd.
"The findings of both studies support a growing body of research that suggests lifestyle interventions lower biomarkers associated with breast cancer recurrence and mortality, ...
Repeated sexual assault victims report more psychological problems than previously thought
2014-05-22
COLUMBIA, Mo. – According to recent studies, one in five adult women and one in 100 adult men have reported being raped. The prevalence increases to two in five among women and one in five among men who report experiencing other forms of sexual violence, such as repeated unwanted sexual contact and sexual coercion. Now, researchers at the University of Missouri have determined that those victims who are repeatedly assaulted, but not necessarily violently raped, show greater levels of psycho-behavioral consequences than earlier thought. The researchers suggest that understanding ...
Male and female sex cell determination requires lifelong maintenance and protection
2014-05-22
MINNEAPOLIS/ST. PAUL (May 22, 2014) – The way in which the sex of an organism is determined may require lifelong maintenance, finds new research from the University of Minnesota. According to the study published today in the journal Developmental Cell, sex-specific transcription factors perform lifelong work to maintain sexual determination and protect against reprogramming of cells from one sex to the other.
Previous research at the University of Minnesota's Department of Genetics, Cell Biology, and Development showed sex determination is not permanent. Using a mouse ...
Study shows how common obesity gene contributes to weight gain
2014-05-22
NEW YORK, NY (May 22, 2014) — Researchers have discovered how a gene commonly linked to obesity—FTO—contributes to weight gain. The study shows that variations in FTO indirectly affect the function of the primary cilium, a little-understood hair-like appendage on brain and other cells. Specific abnormalities of cilium molecules, in turn, increase body weight, in some instances, by affecting the function of receptors for leptin, a hormone that suppresses appetite. The findings, made in mice, suggest that it might be possible to modify obesity through interventions that alter ...
Scientific collections play vital role in conservation biology
2014-05-22
Scientists from the California Academy of Sciences and more than 60 other international research institutions spanning six continents have responded to a recent paper in Science, which questioned current methods of scientific collecting and advocated the use of non-lethal alternatives. The response, led by Luiz Rocha, Ph.D., the Academy's Assistant Curator and Follett Chair of Ichthyology, and co-authored by such science luminaries as Harvard's E. O. Wilson and the Academy's Chief of Science and Sustainability, Margaret (Meg) Lowman, describes in detail the value that scientific ...